CytRx Corporation (OTCMKTS:CYTR) Stock Falls:Company Relaunches as LadRx Corporation
Biopharmaceutical innovator focusing on research and development of life-saving cancer therapeutics, CytRx Corporation (OTCMKTS:CYTR), on September 23, 2022, announced relaunching of the LadRx Corporation. Trading Data On Friday, CYTR stock slid 21.57% to $0.1000 with more than 90.12K shares, compared to its average volume of 68.32K shares. The stock moved within a range of $0.1000 – 0.1275 after opening trading at $0.1003. CytRx Corporation Relaunches as LadRx Corporation Chief Executive…